There is no indication that they have applied for MHRA approval, or do you have some information that they did?. And, I, like many, believe it would not be possible to apply and submit unblinded TLD data without PR'ing it.
dennisdave, please share with us what are the solid indications that lead you to believe that the journal publication has encountered some tough and difficult obstacles and that NWBO had therefore decided to postpone the publication and still go for RA approval.
Also what information do you have that NWBO had requested an MHRA approval and if the MHRA had dismissed the request, production of DCVax-L in the UK would have already been terminated?
Ignoring most of this post as well as it is full of useless rumors, you don’t seem to understand the MHRA process. First there is a GMP commercial application. It is 99.9999% certain that the public will find out about such application long before they find out about an MHRA GMP commercial approval.